05:21 PM EDT, 09/03/2024 (MT Newswires) -- Ascendis Pharma ( ASND ) reported a Q2 loss late Tuesday of 1.91 euros ($2.11) per diluted share, compared with a 2.16 euros loss a year earlier.

Analysts polled by Capital IQ expected a loss of 1.34 euros.

Revenue for the quarter that ended June 30 was 36 million euros, down from 47.4 million euros a year earlier.

Analysts surveyed by Capital IQ expected 84.5 million euros.

Shares of the company traded 13% lower in after-hours activity.

Price: 117.40, Change: -17.28, Percent Change: -12.83